These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10743548)

  • 1. Stopping PCP prophylaxis.
    AIDS Patient Care STDS; 1999 Dec; 13(12):756. PubMed ID: 10743548
    [No Abstract]   [Full Text] [Related]  

  • 2. Pneumocystis carinii prophylaxis can be discontinued after CD4+ cell recovery over 200 x 10(6)/l.
    Rodríguez-Guardado A; Maradona JA; Cartón JA; Casado L; Asensi V
    AIDS; 1998 Dec; 12(17):2355-6. PubMed ID: 9863883
    [No Abstract]   [Full Text] [Related]  

  • 3. Stopping PCP prophylaxis after suppressing HIV.
    Norton M
    GMHC Treat Issues; 1999 Apr; 13(4):4-5. PubMed ID: 11366976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P. carinii prophylaxis in patients with HIV.
    Kirchner JT
    Am Fam Physician; 1999 Nov; 60(7):2094-5. PubMed ID: 10569511
    [No Abstract]   [Full Text] [Related]  

  • 5. Discontinuing Pneumocystis carinii prophylaxis.
    Girard PM
    N Engl J Med; 2001 Jan; 344(3):222-3. PubMed ID: 11172146
    [No Abstract]   [Full Text] [Related]  

  • 6. Discontinuing prophylaxis against Pneumocystis carinii pneumonia.
    Bender MA; Sax PE
    N Engl J Med; 2001 May; 344(21):1639; author reply 1640-1. PubMed ID: 11374364
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention of pneumonia related to HIV--pneumocystis carinii pneumonia (PCP)].
    Sidahora; 1995; ():31-2. PubMed ID: 11363204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumocystis carinii pneumonia in HIV-infected patients.
    May TA; Gruta CI; Goldschmidt RH
    Am Fam Physician; 2000 Oct; 62(8):1783, 1786. PubMed ID: 11057837
    [No Abstract]   [Full Text] [Related]  

  • 9. Discontinuation of secondary prophylaxis for Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients: a randomized trial by the CIOP Study Group.
    Mussini C; Pezzotti P; Antinori A; Borghi V; Monforte Ad; Govoni A; De Luca A; Ammassari A; Mongiardo N; Cerri MC; Bedini A; Beltrami C; Ursitti MA; Bini T; Cossarizza A; Esposito R;
    Clin Infect Dis; 2003 Mar; 36(5):645-51. PubMed ID: 12594647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Help yourself defeat the lung infection called PCP. National Institutes of Health.
    AIDS Alert; 1997 Feb; 12(2):suppl 1. PubMed ID: 11364036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumocystis carinii pneumonia following discontinuation of primary prophylaxis despite highly active antiretroviral therapy.
    Mammen-Tobin A; Monteiro EF
    Int J STD AIDS; 2000 Jan; 11(1):64-5. PubMed ID: 10667904
    [No Abstract]   [Full Text] [Related]  

  • 12. Prophylaxis against Pneumocystis carinii pneumonia at higher CD4+ T-cell counts.
    Chu SY; Hanson DL; Ciesielski C; Ward JW
    JAMA; 1995 Mar; 273(11):848. PubMed ID: 7869553
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimizing PCP therapy.
    Torres G; Cadman J
    GMHC Treat Issues; 1997 Oct; 11(10):3-5. PubMed ID: 11364821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stopping preventive treatments.
    Fornataro K; Jefferys R
    Body Posit; 1999 Jul; 12(7):9-10. PubMed ID: 11367080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low incidence of community-acquired pneumonia among human immunodeficiency virus-infected patients after interruption of Pneumocystis carinii pneumonia prophylaxis.
    Eigenmann C; Flepp M; Bernasconi E; Schiffer V; Telenti A; Bucher H; Wagels T; Egger M; Furrer H;
    Clin Infect Dis; 2003 Apr; 36(7):917-21. PubMed ID: 12652393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interruption of prophylaxis for major opportunistic infections in HIV-infected patients receiving triple combination antiretroviral therapy.
    Jubault V; Pacanowski J; Rabian C; Viard JP
    Ann Med Interne (Paris); 2000 May; 151(3):163-8. PubMed ID: 10896967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription of Pneumocystis Jiroveci Pneumonia Prophylaxis in HIV-Infected Patients.
    Lin X; Garg S; Mattson CL; Luo Q; Skarbinski J
    J Int Assoc Provid AIDS Care; 2016 Nov; 15(6):455-458. PubMed ID: 27629868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumocystis pneumonia in a person with a low CD4 count after stopping antiretroviral therapy.
    Ball SC
    AIDS Read; 2007 Dec; 17(12):583-6, 593. PubMed ID: 18178976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PCP prophylaxis in paediatric HIV infection: time for a change?
    Kovacs JA; Kovacs AA
    Lancet; 1994 Jul; 344(8914):5-6. PubMed ID: 7912309
    [No Abstract]   [Full Text] [Related]  

  • 20. PCP prevention--more cases of resistance to sulfa drugs.
    TreatmentUpdate; 1998 Sep; 10(7):3-5. PubMed ID: 11365781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.